Licensing Agreement

Gobivaz Biosimilar Earns EEA Approval, Expanding Access to Anti-TNF Therapy

Reykjavik & London, November 2025 Alvotech and Advanz Pharma have received marketing approval across the European Economic Area (EEA)...

By cGxPwire Editor
November 20, 2025

Veterinary

PetVivo & Digital Landia Reveal AI Framework Transforming Veterinary Care

Dateline – November 17 2025 | Minneapolis & Miami PetVivo Holdings, Inc. announced that its exclusive AI-technology partner, Digital...

By cGxPwire Editor
November 17, 2025

Bio-Pharma

VectorY and ShapeTX Partner to Advance AAV5-Based CNS Therapies

AMSTERDAM, BOSTON, and SEATTLE – Sept. 18, 2025 (cGxP.wire) – VectorY Therapeutics, a biotechnology company pioneering vectorized antibody therapies...

By cGxPwire Editor
September 18, 2025

Bio-Pharma

Monte Rosa and Novartis Expand Degrader Alliance in Immunology

BOSTON, Mass., September 15, 2025 – Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company pioneering molecular glue...

By cGxPwire Editor
September 15, 2025

We work Hard to get you posted with latest updates

Unwrap our new Directory

Gobivaz Biosimilar Earns EEA Approval, Expanding Access to Anti-TNF Therapy

PetVivo & Digital Landia Reveal AI Framework Transforming Veterinary Care

VectorY and ShapeTX Partner to Advance AAV5-Based CNS Therapies

Monte Rosa and Novartis Expand Degrader Alliance in Immunology